Beruflich Dokumente
Kultur Dokumente
ZEESHAN YOUSUF MEDICAL TECHNOLOGIST AGA KHAN UNIVERSITY HOSPITAL KARACHI, PAKISTAN
The Basics..
As you recall,
Antibody Screens use 2 or 3 Screening Cells to detect if antibodies are present in the serum If antibodies are detected, they must be identified
present
Not present
Antibody identification is needed for transfusion purposes and is an important component of compatibility testing It will identify any unexpected antibodies in the patients serum If a person with an antibody is exposed to donor cells with the corresponding antigen, serious side effects can occur
Key Concepts
When detecting and/or identifying antibodies, we test patient serum (unknown) with reagent RBCs (known)
Reagent RBCs
Screening Cells and Panel Cells are the same with minor differences:
Screening cells
Antibody detection Sets of 2 or 3 vials
Panel cells
Antibody identification At least 10 vials per set
An antibody panel is just an extended version of an antibody screen The screen only uses 2-3 cells:
Antibody Panel
Panel
Panel
Each of the panel cells has been antigen typed (shown on antigram)
+ refers to the presence of the antigen 0 refers to the absence of the antigen
Example: Panel Cell #10 has 9 antigens present: c, e, f, M, s, Leb, k, Fya, and Jka
Panel
Panel
37
AHG
Antibody ID Testing
A tube is labeled for each of the panel cells plus one tube for AC:
3 4 5 6 7 8 9 10 11
AC
IS Phase
Perform immediate spin (IS) and grade agglutination; inspect for hemolysis Record the results in the appropriate space as shown:
2+ 0 0
Last tube
2 drops of LISS are added, mixed and incubated for 10-15 minutes Centrifuge and check for agglutination Record results
Indirect Antiglobulin Test (IAT) were testing whether or not possible antibodies in patients serum will react with RBCs in vitro To do this we use the Anti-Human Globulin reagent (AHG)
AHG Phase
Wash cells 3 times with saline (manual or automated) Add 2 drops of AHG and gently mix
AHG Phase
2+ 0 0 2+ 0 0 2+ 0 2+ 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
IS 2+ 0 0 2+ 0 0 2+ 0 2+ 0 0
LISS AHG 37 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
CC
All cells are negative at AHG, so add Check Cells
2+ 0 0 2+ 0 0 2+ 0 2+ 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
??
2.
3.
4.
Ruling out means crossing out antigens that did not react Circle the antigens that are not crossed out Consider antibodys usual reactivity Look for a matching pattern
Always remember: An antibody will only react with cells that have the corresponding antigen; antibodies will not react with cells that do not have the antigen
Heres an example:
1. Ruling Out
2+ 0 0 2+ 0 0 2+ 0 2+ 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cross out antigens that show NO REACTION in any phase; do NOT cross out heterozygous antigens that show dosage.
2+ 0 0 2+ 0 0 2+ 0 2+ 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
Lea is normally a Cold-Reacting antibody (IgM), so it makes sense that we see the reaction in the IS phase of testing; The E antigen will usually react at warmer temperatures
2+ 0 0 2+ 0 0 2+ 0 2+ 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
Interpretation
antiLea
Guidelines
Autocontrol Negative - alloantibody Positive autoantibody or DTR (i.e.,alloantibodies) Phases IS cold (IgM) 37 - cold (some have higher thermal range) or warm reacting AHG warm (IgG)significant!! Reaction strength 1 consistent strength one antibody Different strengths multiple antibodies or dosage
If panel cells are homozygous, a strong reaction may be seen If panel cells are heterozygous, reaction may be weak or even nonreactive
Panel cells that are heterozygous should not be crossed out because antibody may be too weak to react (see first example)
Guidelines (continued)
Single antibodies usually shows a pattern that matches one of the antigens (see previous panel example) Multiple antibodies are more difficult to match because they often show mixed reaction strengths
Rule of three
The rule of three must be met to confirm the presence of the antibody A p-value 0.05 must be observed This gives a 95% confidence interval How is it demonstrated?
3 Positive cells
3 Negative cells
Panel Cells 1, 4, and 7 are positive for the antigen and gave a reaction at immediate spin Panel Cells 8, 10, and 11 are negative for the antigen and did not give a reaction at immediate spin
If there are not enough cells in the panel to fulfill the rule, then additional cells from another panel could be used Most labs carry different lot numbers of panel cells
Phenotyping
In addition to the rule of three, antigen typing the patient red cells can also confirm an antibody How is this done?
Only perform this if the patient has NOT been recently transfused (donor cells could react) If reagent antisera (of the suspected antibody) is added to the patient RBCs, a negative reaction should resultWhy?
Multiple antibodies
Selected Cells
Selected cells are chosen from other panel or screening cells to confirm or eliminate the antibody The cells are selected from other panels because of their characteristics The number of selected cells needed depends on how may antibodies are identified
Selected Cells
Every cell should be positive for each of the antibodies and negative for the remaining antibodies For example:
Lets say you ran a panel and identified 3 different antibodies: anti-S, anti-Jka, and anti-P1 Selected cells could help
Selected Cells
Selected cells S Jka P1 IS LISS AHG 37
#1
#5
+
0
0
+
0
0
0
0
0
0
2+
3+
#8
These results show that instead of 3 antibodies, there are actually 2: anti-S and anti-Jka
Neutralization
Some antibodies may be neutralized as a way of confirmation Commercial substances bind to the antibodies in the patient serum, causing them to show no reaction when tested with the corresponding antigen (in panel)
Neutralization
Manufacturers directions should be followed and a dilutional control should always be used
The control contains saline and serum (no substance) and should remain positive A control shows that a loss of reactivity is due to the neutralization and not to the dilution of the antibody strength when the substance is added
Neutralization
Common substances
P1 substance (sometimes derived from hydatid cyst fluid) Lea and Leb substance (soluble antigen found in plasma and saliva) I substance can be found in breast milk Sda substance derived from human or guinea pig urine
**you should be aware that many of these substances neutralize COLD antibodies; Cold antibodies can sometimes mask more clinically significant antibodies (IgG), an important reason to use neutralization techniques
Enzymes (proteolytic)
Can be used to enhance or destroy certain blood group antigens Several enzymes exist:
One-step Two-step
Enzymes
Enzymes remove the sialic acid from the RBC membrane, thus destroying it and allowing other antigens to be enhanced Antigens destroyed: M, N, S, s, Duffy Antigens enhanced: Rh, Kidd, Lewis, I, and P
Enzyme techniques
One-stage
Enzyme is added directly to the serum/cell mixture Panel cells are pre-treated with enzyme, incubated and washed Patient serum is added to panel cells and tested
Two-stage
Enzyme techniques
If there is no agglutination after treatment, then it is assumed the enzymes destroyed the antigen
Enzyme treatment
Enzyme treament
Anti-K
Sulfhydryl Reagents
Cleave the disulfide bonds of IgM molecules and help differentiate between IgM and IgG antibodies Good to use when you have both IgG and IgM antibodies (warm/cold)
Dithiothreitol (DTT) is a thiol and will denature Kell antigens 2-mercaptoethanol (2-ME)
ZZAP
A combination of proteolytic enzymes and DTT Denatures Kell, M, N, S, Duffy and other less frequent blood group antigens Does not denature the Kx antigen Good for adsorption techniques
frees autoantibody off patients cell, so that autoantibody can then be adsorbed onto another RBC
Autoantibodies.
Warm & Cold Reacting
Autoantibodies
Autoantibodies can be cold or warm reacting A positive autocontrol or DAT may indicate that an auto-antibody is present Sometimes the autocontrol may be positive, but the antibody screening may be negative, meaning something is coating the RBC
We have focused a lot on the IAT used in antibody screening and ID, but what about the DAT? The direct antiglobulin test (DAT) tests for the in vivo coating of RBCs with antibody (in the body) AHG is added to washed patient red cells to determine this
Although not always performed in routine pretransfusion testing, a positive DAT can offer valuable information
If the patient has been transfused, the patient may have an alloantibody coating the transfused cells If the patient has NOT been transfused, the patient may have an autoantibody coating their own cells
Identifying autoantibodies
Auto-antibodies can sometimes mask clinically significant alloantibodies, so its important to differentiate between auto- and allo-antibodies
Cold autoantibodies
React at room temperature with most (if not all) of the panel cells and give a positive autocontrol The DAT is usually positive with anti-C3 AHG (detects complement) Could be due to Mycoplasma pneumoniae, infectious mono, or cold agglutinin disease
Cold autoantibodies
Mini-cold panels can be used to help identify cold autoantibodies Since anti-I is a common autoantibody, cord blood cells (no I antigen) are usually included
Group O individual with cold autoanti-I
Avoiding reactivity
Cold autoantibodies can be a nuisance at times. Here are a few ways to avoid a reaction:
Use anti-IgG AHG instead of polyspecific. Most cold antibodies react with polyspecific AHG and anti-C AHG because they fix complement Skipping the IS phase avoids the attachment of cold autoantibodies to the red cells Use 22% BSA instead of LISS
Other techniques
Red cells, serum, and saline are incubated at 37 before being combined
Autoadsorption is another technique in which the autoantibody is removed from the patients serum using their own red cells
Warm autoantibodies
More common that cold autoantibodies Positive DAT due to IgG antibodies coating the red cell Again, the majority of panel or screening cells will be positive The Rh system (e antigen) seems to be the main target although others occur
Warm autoantibodies
Cause warm autoimmune hemolytic anemia (WAIHA)H&H How do you get a warm autoantibody?
Idiopathic Known disorder (SLE, RA, leukemias, UC, pregnancy, infectious diseases, etc) Medications
Sensitized RBC
Y
Positive DAT
Frees antibody
Y
Antibody ID
Y
Elution
Elution
The eluate is a term used for the removed antibodies Testing the eluate is useful in investigations of positive DATs
The red cells can also be used after elution for RBC phenotyping if needed When tested with panel cells, the eluate usually remains reactive with all cells if a warm autoantibody is present
Elution Methods
ABO antibodies
Adsorption
Adsorption procedures can be used to investigate underlying alloantibodies ZZAP or chloroquine diphosphate can be used to dissociate IgG antibodies from the RBC (may take several repeats) After the patient RBCs are incubated, the adsorbed serum is tested with panel cells to ID the alloantibody (if present)
Adsorption
Two types:
Autoadsorption
No recent transfusion Autoantibodies are removed using patient RBCs, so alloantibodies can be identified
2 tubes
Wash x3 after incubation Centrifuge after incubating; and transfer serum to 2nd tube of treated cells; incubate and centrifuge again
More reagents.
Many of elution tests can damage the antigens on the RBC Choroquine diphosphate (CDP) and glycine acid EDTA reagents can dissociate IgG from the RBC without damaging the antigens
Chloroquine diphosphate
Quinilone derivative often used as an antimalarial May not remove autoantibody completely from DAT positive cells Partial removal may be enough to antigen type the cells or to be used for autoadsorption of warm autoantibodies
THE END!!
THANK YOU